ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2023

Dec 13, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2023-12-07

Reporting Person: Woods Keith (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-07	Stock Option (Right to Buy)	$26.3	A	20522	Acquired	2033-12-07	Common Stock (20522)	Direct
2023-12-07	Stock Option (Right to Buy)	$26.3	A	11960	Acquired	2033-12-07	Common Stock (11960)	Direct

Footnotes

F1: This option represents a right to purchase a total of 20,522 shares of the Issuer's common stock, which will vest in equal monthly installments over a three-year period, such that all of the shares underlying this option will be fully vested on December 7, 2026.

F2: This option represents a right to purchase a total of 11,960 shares of the Issuer's common stock, which will fully vest on December 7, 2024.